Irvine, Calif., Oct. 3, 2024 鈥� With an initial three-year, $33 million grant from the National Institute of Allergy and Infectious Diseases, the University of California, Irvine will lead a multi-institutional drive to create new vaccines as part of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness Network (ReVAMPP).
A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.
Researchers at Wake Forest University School of Medicine have received a five-year, $3.4 million grant from the National Institute on Aging, part of the National Institutes of Health, to study medical misinformation.
September usually marks the start of flu season, and with the ongoing threat of COVID-19, it鈥檚 crucial to be vigilant about your family鈥檚 health. The challenge, however, is being able to tell the difference between the flu, the common cold, respiratory syncytial virus (RSV) and COVID-19, since all have similar symptoms.
New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity鈥攁nd potentially better pandemic preparedness.
.jpg&width=300&height=300)
A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 欧美极品 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
